Author:
Kako Bashar,Romero Alvaro Badenes,Queiroz Marcelo A.,Galgano Samuel J.,Caravan Peter,Esfahani Shadi Abdar
Reference104 articles.
1. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: Biodistribution in humans and first evaluation of tumour lesions;Afshar-Oromieh;European Journal of Nuclear Medicine and Molecular Imaging,2013
2. Physiological uptake in FDG PET simulating disease;Ahmad Sarji;Biomedical Imaging and Intervention Journal,2006
3. F-sodium fluoride PET: History, technical feasibility, mechanism of action, normal biodistribution, and diagnostic performance in bone metastasis detection compared with other imaging modalities;Ahuja;Journal of Nuclear Medicine Technology,2020
4. Change in salvage radiotherapy management based on guidance with FACBC (fluciclovine) PET/CT in postprostatectomy recurrent prostate cancer;Akin-Akintayo;Clinical Nuclear Medicine,2017
5. The latest developments in imaging of fibroblast activation protein;Altmann;Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine,2021